|
Sign In to gain access to subscriptions and/or personal tools.
|
In vivo effect of enalapril on lysosomal compartment isolated from kidney and liver of rats
Reinaldo Martinelli
Renal Service, Federal University of Bahia, Medical School, Salvador, Bahia, Brazil, rm{at}ufba.br
Claudia VCD Santos
Laboratory of Basic Research, EBMSP, Fundação para o Desenvolvimento Ciência, Salvador, Bahia, Brazil
Marcel L Albuquerque
Medical Student, EBMSP
Aline M Silva
Medical Student, EBMSP
Luiz Erlon Rodrigues
Laboratory of Basic Research, EBMSP, Fundação para o Desenvolvimento Ciência, Salvador, Bahia, Brazil
Introduction. Angiotensin II (Ang II) inhibitory agents such as angiotensin-converting enyzme (ACE) inhibitors have been used as antihypertensive and anti-proteinuric drugs, attenuating the progression and inducing regression of glomerulosclerosis.The mechanisms related to the renoprotective effects of the ACE-inhibitors, although partly related to the blockade of the renin-angiotensin system (RAS), are not completely understood.Their effects on many cellular functions and intracellular components have not been directly studied.The aim of the present studies was to investigate the effect of enalapril on lysosomal activity.
Material and methods. Two groups of Wistar rats were studied.The experimental group received enalapril, 50 mg/L, in the drinking water; the control group was submitted to the same conditions except for enalapril. After two weeks of treatment, each animal was sacrificed and samples of liver and kidney were individually collected, homogenised and subjected to differential centrifugation.The supernatant was utilised for evaluation of ortophosphoricmonoester phosphohydrolase as a marker of lysosome stability and the results expressed as specific units of phosphatase activity.
Results. The mean specific activities of the lysosomal compartment isolated from kidneys of enalapril-treated rats showed a mean specific activity that was 17.6% higher than the control group; no difference was found in the liver.
Conclusion. The present studies suggests that the beneficial effect of enalapril is not related to effects on lysosomal membrane.
Key Words: effects • enalapril • kidney • liver • lysosomal compartment • membrane stability
References
- Lafayette RA, Mayer P., Park SK, Meyer TW Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-71.[Web of Science][Medline]
[Order article via Infotrieve]
- Noris M., Mister M., Pezzota A. et al. ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established. Kidney Int 2003;64:2253-61.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ruggenenti P., Perna A., Gherardi G., Benini G., Remuzzi G.: Chronic proteinuric nephropathies. Outcome and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 2000;35:1155-65.[Web of Science][Medline]
[Order article via Infotrieve]
- Rugale C., Cordaillat M., Mimran A., Bernard J. Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension. JRAAS 2005;6:154-60.[Medline]
[Order article via Infotrieve]
- Ma LJ, Nakamura S., Aldigier JC et al. Regression of glomerulosclerosis with high-dose angiotensin inhibitor is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 2005;16:966-76.[Abstract/Free Full Text]
- Nakao N., Seno H., Kasuga H., Toriyama T., Kawahara H. Dual blockade of the rennin-angiotensin system in chronic renal disease. Clin Exp Nephrol 2004;8:183-7.[CrossRef][Medline]
[Order article via Infotrieve]
- Osicka TM, Kiriazis Z., Pratt LM, Jerums G., Comper WD Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats. Diabetologia 2001;44:230-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Remuzzi A., Gagliardini E., Donadoni C. et al. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int 2002;62:885-94.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Russo LM, Brammar GC, Jerums G., Comper WD, Osicka TM The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-β expression. J Hypertens 2003;21:419-28.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ruggenenti P., Perna A., Lariga G., Ene-lordache B. et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomized controlled trial. Lancet 2005;365:939-46.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Casas JP, Chua W., Loukogeorgakis S. et al: Effect of inhibition of the rennin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005;366:2026-33.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ferder L., Inserra F., Romano L., Ercole L., Pszenny V. Effects of angiotensin-converting anzyme inhibition on mitochondral number in the aging mouse. Am J Physiol 1993;265:C15-C18.[Web of Science][Medline]
[Order article via Infotrieve]
- Shin G.-T, Kim S.-J., Ma K-A., Kim H.-S, Kim D. ACE inhibitor attenuate expression of renal transforming growth factor-β in humans. Am J Kidney Dis 2000;36:894-902.[Web of Science][Medline]
[Order article via Infotrieve]
- Stenvinkel P., Andersson P., Wang T. et al. Do ACE-inhibitor suppress tumor necrosis factor-β production in advanced chronic renal failure? J Intern Med 1999;246:503-07.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Russo LM, Osicka TM, Bonnet F., Jerums G., Comper WD Albuminuria in hypertension is linked to altered lysosomal activity and TGF-β1 expression. Hypertension 2002;39:281-6.[Abstract/Free Full Text]
- Iseki K., Ikemiya Y., Iseki C., Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;63:1468-74.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rodrigues Lea, Paes IB, Jacobina H. Role of lysosomes on human ulcerogenic gastropathies, Effect of zinc ion on the lysosomal stability. Arq Gastroenterol 1998;35:247-51.[Medline]
[Order article via Infotrieve]
- Brunk UT Lysosomotropic detergents induce time- and dose-dependent apoptosis/necrosis in cultured cell. Redox Report 2000;5:87-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Cajaraville MP, Bebianno MJ, Blasco J., Porte C., Sarasquete C., Viarengo A. The use of biomarkers to assess the impact of pollution in coastal environments of the Iberian Peninsula: a practical approach. Sci Total Environ Mar 2000;247:325-9.
- Marchi B., Burlando B., Moore MN, Viarengo A. Mercury-and copper-induced lysosomal membrane destabilisation depends on [Ca2+]i dependent phospholipase A2 activation. Aquat Toxicol 2004;66:197-204.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Komsa-Penkova R., Spirova R., Bechev B. Modification of Lowry's method for collagen concentration measurement. J Biochem Biophys Methods 1996;32:33-43.[Medline]
[Order article via Infotrieve]
- Viarengo A., Marro A., Marchi B., Burlando B. Single and combined effects of heavy metals and hormones on lysosomes of haemolymph cells from the mussel Mytilus galloprovincialis. Mar Biol 2000;137:907-12.[CrossRef]
- Camejo G. Hydrolytic enzymes released from resident macrophages and located in intima extracellular matrix as agents that modify retained apolipoprotein B lipoproteins. Arterioscler Thromb Vasc Biol 2003;23:1312-13.[Free Full Text]
- Hakala J., Oksjoki R., Laine P. Du H., Grabowski G., Kovanen P., Pentikaiinen M. Lysosomal enzymes released from cultured human macrophages hydrolyze LDL in vitro and are present extracellularly in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2003;23:1430-6.[Abstract/Free Full Text]
- Ishisaka R., Utsumi T., Yabuki M., Kanno T., Furuno T., Inoue M., Utsumi K. Activation of caspase-3-like protease by digitonin-treated lysosomes. FABS Lett 1998:435:233-6.[CrossRef]
- Marigómez I., Lekube X., Cajaraville MP, Domouhtsidou G., Dimitriades V. Comparison of cytochemical procedures to estimate lysosomal biomarkers in mussel digestive cells. Aquat Toxicol 2005;75:86-95.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Petrovich S., Semencic L., Ozretic B., Ozretic M. Seasonal variations of physiological and cellular biomarkers and their use in the biomonitoring of north Adriatic coastal water (Croatia). Mar Pollut Bull 2004;49:713-20.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Adamczac M., Gross ML, Krtil J., Koch A., Amann K., Ritz E. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomised rats. J Am Soc Nephrol 2003;14:2833-42.[Abstract/Free Full Text]
- Remuzzi G., Remuzzi A. Is regression of chronic nephropathies a therapeutic target? J Am Soc Nephrol 2005; 16:840-2.[Free Full Text]
- Taal MW, Brenner BM Renoprotective benefits of RAS inhibition. From ACE inhibitor to angiotensin II antagonists. Kidney Int 2000;57:1803-17.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Suzuki H., Schaefer L., Ling H. et al. Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration: Potential role of lysosomal proteinases. Am J Nephrol 1995;15:129-36.[Web of Science][Medline]
[Order article via Infotrieve]
- Izuhara Y., Nangaku M., Inagi R. et al. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 2005;16:3631-41.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 3,
105-109 (2007)
DOI: 10.3317/jrass.2007.013
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
